Holen Sie sich die Stockscreener-App
1.8184
2.15%
-0.0416
Schlusskurs vom Vortag:
$1.86
Offen:
$1.85
24-Stunden-Volumen:
45,886
Relative Volume:
0.12
Marktkapitalisierung:
$212.66M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-13.73M
KGV:
-13.99
EPS:
-0.13
Netto-Cashflow:
$-3.92M
1W Leistung:
-6.67%
1M Leistung:
-7.61%
6M Leistung:
+42.19%
1J Leistung:
+100.64%
1-Tages-Spanne:
$1.81
$1.85
1-Wochen-Bereich:
$1.78
$1.96
52-Wochen-Spanne:
$0.6295
$2.60
Tiziana Life Sciences Ltd Stock (TLSA) Company Profile
Firmenname
Tiziana Life Sciences Ltd
Sektor
Branche
Telefon
-
Adresse
-
Vergleichen Sie TLSA mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
TLSA
Tiziana Life Sciences Ltd
|
1.82 | 221.01M | 0 | -13.73M | -3.92M | -0.13 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.88 | 109.22B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
634.80 | 67.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
427.20 | 57.35B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
842.99 | 50.87B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
185.95 | 39.72B | 447.02M | -1.18B | -868.57M | -6.1812 |
Tiziana Life Sciences Ltd Stock (TLSA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2020-12-22 | Eingeleitet | B. Riley Securities | Buy |
| 2018-12-17 | Eingeleitet | Laidlaw | Buy |
Tiziana Life Sciences Ltd Aktie (TLSA) Neueste Nachrichten
Is Tiziana Life Sciences Ltd stock a buy before product launchesGap Down & Weekly High Return Forecasts - newser.com
Is Tiziana Life Sciences Ltd stock entering bullish territoryMarket Weekly Review & Daily Growth Stock Investment Tips - newser.com
How Tiziana Life Sciences Ltd stock compares to industry benchmarksJuly 2025 Gainers & Free Safe Entry Trade Signal Reports - newser.com
How to use a screener to detect Tiziana Life Sciences Ltd breakoutsTrade Volume Report & Daily Technical Stock Forecast Reports - newser.com
Applying chart zones and confluence areas to Tiziana Life Sciences Ltd2025 Technical Overview & Low Volatility Stock Recommendations - newser.com
Analyzing recovery setups for Tiziana Life Sciences Ltd investorsQuarterly Profit Review & Expert Approved Momentum Ideas - newser.com
Will Tiziana Life Sciences Ltd stock recover faster than market2025 Risk Factors & Safe Capital Growth Trade Ideas - newser.com
Using portfolio simulators with Tiziana Life Sciences Ltd includedWeekly Investment Report & Verified Momentum Watchlists - newser.com
What technical signals suggest for Tiziana Life Sciences Ltd stockOptions Play & Advanced Swing Trade Entry Plans - newser.com
How Tiziana Life Sciences Ltd stock valuations compare to rivalsStop Loss & Accurate Trade Setup Notifications - newser.com
Is Tiziana Life Sciences Ltd stock recession proof2025 Investor Takeaways & Safe Investment Capital Preservation Plans - newser.com
Applying big data sentiment scoring on Tiziana Life Sciences LtdRate Cut & Verified Momentum Watchlists - newser.com
Can momentum traders help lift Tiziana Life Sciences LtdMarket Rally & Verified Momentum Stock Watchlist - newser.com
Can Tiziana Life Sciences Ltd stock outperform in 2025 bull marketSell Signal & Technical Analysis for Trade Confirmation - newser.com
Will a bounce in Tiziana Life Sciences Ltd offer an exit2025 Risk Factors & High Win Rate Trade Alerts - newser.com
How to manage a losing position in Tiziana Life Sciences Ltd2025 Bull vs Bear & High Return Trade Opportunity Guides - newser.com
Tiziana Life Sciences: Foralumab's Intranasal Push Is A Good Moonshot (NASDAQ:TLSA) - Seeking Alpha
Published on: 2025-10-31 05:15:32 - newser.com
Reversal indicators forming on Tiziana Life Sciences Ltd stockTrade Volume Report & Capital Efficiency Focused Strategies - newser.com
Has Tiziana Life Sciences Ltd found a price floorWeekly Profit Recap & AI Optimized Trade Strategies - newser.com
Tiziana Life Sciences to Present at BIO-Europe in Vienna, Highlighting Innovative Immunomodulation Therapy - The Manila Times
Tiziana (Nasdaq: TLSA) to present at BIO-Europe on intranasal foralumab for na‑SPMS, MSA - Stock Titan
Finanzdaten der Tiziana Life Sciences Ltd-Aktie (TLSA)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.71%
0.18%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):